ShailenRShahMD

PubMed

• 8 citations
  The Efficacy and Tolerability of Inhaled Montelukast Plus Inhaled Mometasone Compared with Mometasone Alone in Patients with Chronic Asthma
  George Philip, César Villarán, Shailen R. Shah, Kristel Vandormael, Steven S. Smugar, Theodore F. Reiss> ;Journal of Asthma. 2011 May 23
• Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipid...
  Shah, S.,Ceska, R.,Gil-Extremera, B.,Paolini, J. F.,Giezek, H.,Vandormael, K.,Mao, A.,McCrary Sisk, C.,Maccubbin, D.> ;Int. J. Clin. Pract.. 2010 Jun 04
• 30 citations
  Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in ...
  William W. Busse, Shailen R. Shah, Laura Somerville, Bhash Parasuraman, Paula Martin, Mitchell Goldman> ;The Journal of Allergy and Clinical Immunology. 2008 Jun 1
• Rationale for the administration of acellular pertussis vaccine to parents of infants in the neonatal intensive care unit.
  Shah, S.,Caprio, M.,Mally, P.,Hendricks-Munoz, K.> ;J Perinatol. 2006 Dec 21
• 8 citations
  Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis.
  Nancy C. Santanello, Carla DeMuro-Mercon, Shailen R. Shah, Eric J. Schenkel, Paul H. Ratner, S. Balachandra Dass, Josephine M. Norquist, George Philip> ;Allergy and Asthma Proceedings. 2006 May 1
• 27 citations
  Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate n...
  Shailen R. Shah, Christopher J. Miller, Ned Pethick, Thomas Uryniak, M. Kathryn C. Jones, L. O'Dowd> ;Clinical Therapeutics. 2003 Aug 1
• 22 citations
  Latex allergy and latex sensitization in children and adolescents with meningomyelocele
  Shailen R. Shah, Michael F. Cawley, Roz Gleeson, John C O'Connor, Stephen M McGeady> ;The Journal of Allergy and Clinical Immunology. 1998 Jun 1
• Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
  Shah, S.,Berger, W.,Lumry, W.,La Force, C.,Wheeler, W.,Sacks, H.> ;Allergy Asthma Proc. 2009 Nov 26
• Join now to see all